RMD Q2 2021 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$35B

Q2 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$800M+8.7% YoY

Gross Profit

$462M57.8% margin

Operating Income

$222M27.7% margin

Net Income

$180M22.4% margin

EPS (Diluted)

$1.23

QoQ Revenue Growth

+6.4%

Cash Flow

Operating Cash Flow

$170M

Free Cash Flow

$132M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$4.6B

Total Liabilities

$1.7B

Stockholders' Equity

$2.9B

Cash & Equivalents

$256M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$800M	$736M	+8.7%
Gross Profit	$462M	$427M	+8.3%
Operating Income	$222M	$198M	+12.1%
Net Income	$180M	$161M	+11.8%

Revenue Segments

Devices And Masks

$708M89%

Software As Service

$92M11%

Geographic Segments

Us Canada And Latin America

$519M65%

Combined Europe Asia And Other Markets

$281M35%